Upsher-Smith Laboratories, LLC has launched Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, 2.5 mg/0.025 mg.

The product is an AA-rated generic version of the branded product, Lomotil* (diphenoxylate hydrochloride and atropine sulfate tablets), a combination prescription drug used to treat the symptoms of acute or chronic diarrhea. 

The diphenoxylate hydrochloride and atropine sulfate tablet market had U.S. sales of approximately $64 million for the 12 months ending May, 2018 according to IQVIA. 

Product	Strength	NDC #	Package Size
Diphenoxylate Hydrochloride and  Atropine Sulfate Tablets, USP	2.5 mg/0.025 mg	0832-0590-11	Bottle of 100
		0832-0590-10	Bottle of 1,000

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP are classified as a Schedule V controlled substance.

* Lomotil is a registered trademark of G.D. Searle LLC

(Source: Upsher-Smith Laboratories, LLC)